Published Date: 27 Dec 2023
A method for predicting which patients will benefit from radium-223, a common treatment for advanced prostate cancer that has spread to the bones, has been developed by researchers.
Read Full NewsCancer patients aren't just battling a deadly disease—part of their time and energy can also be spent fighting the system intended to cure them, a new study says. The findings are published in the journal JCO Oncology Practice.
October is Breast Cancer Awareness Month, and cancer awareness starts with general breast awareness. Dr. Julie Nangia, medical director of breast oncology at the Dan L Duncan Comprehensive Cancer Center, recommends monthly ...
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph's Health Care London (Lawson), and University Health Network (UHN) has found a novel imaging solution, ...
Loneliness and social isolation are linked to a heightened risk of death from cancer as well as from all causes among those with the disease, finds a pooled data analysis of the available research published online in the ...
1.
Mindfulness-based interventions are advised by cancer organizations to treat patients' anxiety and depression.
2.
Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.
3.
How cancer misinformation exploits the way we think
4.
Scientists discover the 'roadmap' that aggressive cancer uses to spread
5.
In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.
1.
Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA
2.
A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease
3.
Landmark Medical Oncology Trials Redefining Early Breast Cancer Management
4.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
5.
AI in Genomics: Decoding the Human Genome for Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
4.
Navigating the Complexities of Ph Negative ALL - Part XIV
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation